These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Beta blockers in the treatment of neurological disorders].
    Author: Kostić VS.
    Journal: Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():54-8. PubMed ID: 18193812.
    Abstract:
    The role of beta blockers (especially of propranolol, which has been most frequently used) in prophylaxis of migraine and treatment of essential tremor has been evidenced. These are two exceptionally common neurological entities, therefore detailed insight into indications, dose range and side-effects is necessary. Thus, the optimum therapeutical doses of propranolol for prophylaxis of migraine range from 160-240 mg a day, and for treatment of essential tremor from 240-320 mg a day, which, based on our experiences from practice, indicates that a large number of patients is receiving suboptimal doses, being, consequently, devoid of the best therapeutical effect.
    [Abstract] [Full Text] [Related] [New Search]